Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
2.360
-0.020 (-0.84%)
Mar 6, 2026, 4:00 PM EST - Market closed
Accendra Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,762 | 2,680 | 2,553 | 9,955 | 9,785 | Upgrade
|
| Revenue Growth (YoY) | 3.06% | 5.00% | -74.36% | 1.74% | 15.39% | Upgrade
|
| Cost of Revenue | 1,473 | 1,400 | 1,336 | 8,037 | 8,272 | Upgrade
|
| Gross Profit | 1,289 | 1,280 | 1,217 | 1,919 | 1,513 | Upgrade
|
| Selling, General & Admin | 1,069 | 1,084 | 1,004 | 1,557 | 1,079 | Upgrade
|
| Amortization of Goodwill & Intangibles | 73.83 | 39.85 | 57.8 | 78.97 | 39.77 | Upgrade
|
| Other Operating Expenses | - | - | - | -6.15 | -8.49 | Upgrade
|
| Operating Expenses | 1,143 | 1,124 | 1,062 | 1,630 | 1,111 | Upgrade
|
| Operating Income | 146.21 | 156.47 | 155.31 | 288.89 | 402.6 | Upgrade
|
| Interest Expense | -113.88 | -107.57 | -116.77 | -128.89 | -48.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0.9 | -2.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -13.83 | -1.77 | -2.46 | -1.03 | -0.92 | Upgrade
|
| EBT Excluding Unusual Items | 18.49 | 47.13 | 36.08 | 158.06 | 351.3 | Upgrade
|
| Merger & Restructuring Charges | -120.45 | -68.81 | -24.34 | -54.9 | -34.11 | Upgrade
|
| Impairment of Goodwill | - | -307.11 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -92.28 | - | Upgrade
|
| Other Unusual Items | - | -1.1 | 3.52 | - | -40.43 | Upgrade
|
| Pretax Income | -101.95 | -329.89 | 15.27 | 10.89 | 276.75 | Upgrade
|
| Income Tax Expense | 0.73 | 20.85 | 6.36 | -11.5 | 55.17 | Upgrade
|
| Earnings From Continuing Operations | -102.68 | -350.74 | 8.91 | 22.39 | 221.59 | Upgrade
|
| Earnings From Discontinued Operations | -997.96 | -11.95 | -50.21 | - | - | Upgrade
|
| Net Income | -1,101 | -362.69 | -41.3 | 22.39 | 221.59 | Upgrade
|
| Net Income to Common | -1,101 | -362.69 | -41.3 | 22.39 | 221.59 | Upgrade
|
| Net Income Growth | - | - | - | -89.90% | 641.82% | Upgrade
|
| Shares Outstanding (Basic) | 77 | 77 | 76 | 74 | 73 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 77 | 77 | 76 | 75 | Upgrade
|
| Shares Change (YoY) | 0.20% | -0.81% | 1.51% | 0.97% | 18.85% | Upgrade
|
| EPS (Basic) | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 | Upgrade
|
| EPS (Diluted) | -14.32 | -4.73 | -0.54 | 0.29 | 2.94 | Upgrade
|
| EPS Growth | - | - | - | -90.14% | 523.69% | Upgrade
|
| Free Cash Flow | -292.75 | -8.79 | 568.34 | 166.92 | 83.19 | Upgrade
|
| Free Cash Flow Per Share | -3.81 | -0.12 | 7.35 | 2.19 | 1.10 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.010 | Upgrade
|
| Gross Margin | 46.68% | 47.77% | 47.68% | 19.27% | 15.46% | Upgrade
|
| Operating Margin | 5.29% | 5.84% | 6.08% | 2.90% | 4.11% | Upgrade
|
| Profit Margin | -39.85% | -13.53% | -1.62% | 0.22% | 2.27% | Upgrade
|
| Free Cash Flow Margin | -10.60% | -0.33% | 22.26% | 1.68% | 0.85% | Upgrade
|
| EBITDA | 360.74 | 337.75 | 365.68 | 503.55 | 482.92 | Upgrade
|
| EBITDA Margin | 13.06% | 12.60% | 14.33% | 5.06% | 4.93% | Upgrade
|
| D&A For EBITDA | 214.52 | 181.28 | 210.37 | 214.67 | 80.32 | Upgrade
|
| EBIT | 146.21 | 156.47 | 155.31 | 288.89 | 402.6 | Upgrade
|
| EBIT Margin | 5.29% | 5.84% | 6.08% | 2.90% | 4.11% | Upgrade
|
| Effective Tax Rate | - | - | 41.66% | - | 19.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.